DIA会员及用户请点击登录

登录

忘记用户 ID? or 忘记密码?

Not a Member?

创建账户并加入。

Sheraton Pentagon City Hotel

2024 年 03 月 12 日 7:30 上午 - 2024 年 03 月 13 日 3:55 下午

900 South Orme Street, Arlington, VA 22204, USA

Advertising and Promotion Regulatory Affairs Conference

Explore the current state of compliance for marketing both biopharmaceuticals and medical devices.

Session 10B: The Evolving World of Scientific Exchange

Session Chair(s)

Lynn  Bowen, PhD

Lynn Bowen, PhD

Vice President, Regulatory Affairs Advertising Promotion & Labeling

Alkermes, Inc., United States

The numerous and varied opportunities for scientific exchange (reactive and proactive) continue to introduce new challenges. This session aims to provide a regulatory background for these types of communications and discuss different examples of scientific exchange that various companies are currently participating in today, for example, medical booth activities, medical affairs activities, non-CME sponsored symposia, and more.

Learning Objective :
  • Describe the regulatory basis for scientific exchange
  • Evaluate different features of scientific exchange
  • Identify the different considerations in review of proactive scientific exchange

Speaker(s)

Lynn  Bowen, PhD

Scientific Exchange Mock Scenarios and Discussion

Lynn Bowen, PhD

Alkermes, Inc., United States

Vice President, Regulatory Affairs Advertising Promotion & Labeling

Heather  Banuelos, JD

Legal and Regulatory Framework for Scientific Exchange

Heather Banuelos, JD

King & Spalding LLP, United States

Counsel

Janet  Gottlieb, PhD

Proactive Medical Affairs Communications

Janet Gottlieb, PhD

Canopy Life Sciences, United States

Head of Medical Review Solutions

获得信息并保持参与

不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。